ALMS
Price:
$27.2
Market Cap:
$3.36B
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and c...[Read more]
Industry
Biotechnology
IPO Date
2024-06-28
Stock Exchange
NASDAQ
Ticker
ALMS
According to Alumis Inc.’s latest financial reports and current stock price. The company's current ROE is -54.63%. This represents a change of 242.41% compared to the average of -15.95% of the last 4 quarters.
The mean historical ROE of Alumis Inc. over the last ten years is -22.72%. The current -54.63% ROE has changed 140.48% with respect to the historical average. Over the past ten years (40 quarters), ALMS's ROE was at its highest in in the March 2024 quarter at 12.92%. The ROE was at its lowest in in the March 2025 quarter at -58.80%.
Average
-22.72%
Median
-17.54%
Minimum
-113.12%
Maximum
57.33%
Discovering the peaks and valleys of Alumis Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 57.33%
Minimum Annual Increase = -347.61%
Minimum Annual ROE = -113.12%
| Year | ROE | Change |
|---|---|---|
| 2025 | -80.76% | -28.61% |
| 2024 | -113.12% | -347.61% |
| 2023 | 45.69% | -20.31% |
The current ROE of Alumis Inc. (ALMS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-49.40%
5-year avg
-22.72%
10-year avg
-22.72%
Alumis Inc.’s ROE is greater than RAPT Therapeutics, Inc. (-31.83%), greater than Neumora Therapeutics, Inc. Common Stock (-181.70%), less than ADC Therapeutics S.A. (65.27%), greater than Ocugen, Inc. (-127987.50%), greater than Eton Pharmaceuticals, Inc. (-5.68%), greater than Omeros Corporation (-54.39%), greater than Fulcrum Therapeutics, Inc. (-28.54%), greater than Lexicon Pharmaceuticals, Inc. (-18.64%), greater than Bicycle Therapeutics plc (-33.22%), greater than Lineage Cell Therapeutics, Inc. (-152.10%),
| Company | ROE | Market cap |
|---|---|---|
| -31.83% | $959.26M | |
| -181.70% | $295.53M | |
| 65.27% | $141.21M | |
| -127987.50% | $440.84M | |
| -5.68% | $1.26B | |
| -54.39% | $923.15M | |
| -28.54% | $204.81M | |
| -18.64% | $1.09B | |
| -33.22% | $274.24M | |
| -152.10% | $282.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alumis Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alumis Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Alumis Inc.'s ROE?
How is the ROE calculated for Alumis Inc. (ALMS)?
What is the highest ROE for Alumis Inc. (ALMS)?
What is the 3-year average ROE for Alumis Inc. (ALMS)?
What is the 5-year average ROE for Alumis Inc. (ALMS)?
How does the current ROE for Alumis Inc. (ALMS) compare to its historical average?